Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

IDEAYA Biosciences (IDYA) Equity Average (2019 - 2025)

Historic Equity Average for IDEAYA Biosciences (IDYA) over the last 7 years, with Q3 2025 value amounting to $1.0 billion.

  • IDEAYA Biosciences' Equity Average fell 285.92% to $1.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 billion, marking a year-over-year decrease of 285.92%. This contributed to the annual value of $840.1 million for FY2024, which is 7312.3% up from last year.
  • Latest data reveals that IDEAYA Biosciences reported Equity Average of $1.0 billion as of Q3 2025, which was down 285.92% from $991.9 million recorded in Q2 2025.
  • IDEAYA Biosciences' 5-year Equity Average high stood at $1.1 billion for Q4 2024, and its period low was $215.7 million during Q1 2021.
  • For the 5-year period, IDEAYA Biosciences' Equity Average averaged around $582.6 million, with its median value being $417.7 million (2023).
  • Per our database at Business Quant, IDEAYA Biosciences' Equity Average surged by 12778.88% in 2024 and then crashed by 285.92% in 2025.
  • Over the past 5 years, IDEAYA Biosciences' Equity Average (Quarter) stood at $309.6 million in 2021, then rose by 16.0% to $359.1 million in 2022, then skyrocketed by 57.21% to $564.6 million in 2023, then surged by 98.34% to $1.1 billion in 2024, then fell by 8.39% to $1.0 billion in 2025.
  • Its Equity Average stands at $1.0 billion for Q3 2025, versus $991.9 million for Q2 2025 and $1.0 billion for Q1 2025.